We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is... MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells. Show more
MAIA Biotechnology, Inc., (NYSE American: MAIA) (โMAIAโ, the โCompanyโ), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that two of the...
MAIA Biotechnology, Inc., (NYSE American: MAIA) (โMAIAโ, the โCompanyโ), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the FDA...
MAIA Biotechnology, Inc., (NYSE American: MAIA) (โMAIAโ, the โCompanyโ), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has...
Expansion of 2021 clinical supply agreement for Phase 2 clinical trial Next stage of trial to further assess efficacy of THIO in third line non-small cell lung cancer patients MAIA expects new...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.38 | -16.0337552743 | 2.37 | 2.63 | 1.88 | 375726 | 2.12074874 | CS |
4 | -0.11 | -5.2380952381 | 2.1 | 2.63 | 1.83 | 258539 | 2.13459615 | CS |
12 | -0.8 | -28.6738351254 | 2.79 | 3.48 | 1.8 | 170639 | 2.43606879 | CS |
26 | -1.23 | -38.198757764 | 3.22 | 4.24 | 1.8 | 154400 | 2.85539965 | CS |
52 | 0.9 | 82.5688073394 | 1.09 | 5.99 | 0.9901 | 276165 | 2.56017721 | CS |
156 | -2.11 | -51.4634146341 | 4.1 | 9.64 | 0.82 | 227541 | 3.33026997 | CS |
260 | -2.11 | -51.4634146341 | 4.1 | 9.64 | 0.82 | 227541 | 3.33026997 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions